7-fluoro-1-methyl-1,2,3,4-tetrahydronaphthalene | 1350704-30-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 7-fluoro-1-methyl-1,2,3,4-tetrahydronaphthalene
• CAS: 1350704-30-1
• 化学式: C₁₁H₁₃F
• 分子量: 164.223
• InChiKey: OVHRMKLVBJKRGX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-[4-(氟)-苯基]戊烷-1,4-二酮 在 三乙基硅烷 、 四氯化钛 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 以80%的产率得到7-fluoro-1-methyl-1,2,3,4-tetrahydronaphthalene
  参考文献：
  名称：

  A facile preparation of tetralins from arene-1,4-diones using titanium(IV) chloride and triethylsilane

  摘要：

  A facile method for the synthesis of tetralins has been described which uses various substituted phenylpentane-1,4-diones as starting material with a combination of TiCl4/Et3SiH. The synthesis involves three reactions under mild conditions. A mechanism has been proposed for the reductive cyclization through ionic hydrogenation, and titanium(IV) chloride catalyzed cyclization. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2011.10.054

文献信息

• [EN] FUSED 1,4-OXAZEPINES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS<br/>[FR] 1,4-OXAZEPINES CONDENSÉES ET LEURS ANALOGUES ASSOCIÉS EN TANT QU'INHIBITEURS DE BROMODOMAINE BET
  申请人：UNIV MICHIGAN REGENTS

  公开号：WO2017142881A1

  公开（公告）日：2017-08-24

  The present disclosure provides fused 1,4-oxazepines and related analogs represented by Formula (I) and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R1, R2a, R2b, R3a, R3b, R4, R5, A, and Y are as defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a condition or disorder responsive to inhibition of BET bromodomains such as cancer.

  本发明公开了式(I)表示的融合1,4-噁嗪和相关类似物及其药学上可接受的盐、水合物和溶剂化物，其中R1、R2a、R2b、R3a、R3b、R4、R5、A和Y的定义如说明书中所述。本发明还涉及式(I)化合物用于治疗对BET溴结构域抑制有反应的病症或疾病，如癌症的用途。
• Pyrazolopyrimidines for treating CNS disorders
  申请人：Danysz Wojciech

  公开号：US20110212956A1

  公开（公告）日：2011-09-01

  Substituted pyrazolopyrimidine derivatives of formula (I) wherein Y 1 , Y 2 , Y 3 , Y 4 represent N or C—, whereby at least two of the groups Y 1 to Y 4 represent a carbon atom, R 1 represents chloro or bromo, R 2 to R7 represent e.g. hydrogen, methyl or ethyl; and R 10 and R 11 independently represent e.g. hydrogen or C 1 -C 6 alkyl, are potent mGluR5 modulators and are useful for the prevention of acute and chronic neurological disorders.

  公式（I）的替代嘧唑嘧啶衍生物，其中Y1，Y2，Y3，Y4代表N或C-，其中至少有两个Y1至Y4代表碳原子，R1代表氯或溴，R2至R7代表氢，甲基或乙基等基团; 而R10和R11分别代表氢或C1-C6烷基，是有效的mGluR5调节剂，并可用于预防急性和慢性神经系统疾病。
• FUSED 1,4-OXAZEPINES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS
  申请人：The Regents of The University of Michigan

  公开号：EP3416969B1

  公开（公告）日：2021-05-05
• [EN] AMINO-ACID ANILIDES AS SMALL MOLECULE MODULATORS OF IL-17<br/>[FR] ANILIDES D'ACIDES AMINÉS EN TANT QUE MODULATEURS À PETITES MOLÉCULES D'IL-17
  申请人：LEO PHARMA AS

  公开号：WO2020127685A1

  公开（公告）日：2020-06-25

  The present invention relates to a compound according to formula I (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
• A facile preparation of tetralins from arene-1,4-diones using titanium(IV) chloride and triethylsilane
  作者：Gang Li、Qiong Xiao、Chun Li、Xiaojian Wang、Dali Yin

  DOI：10.1016/j.tetlet.2011.10.054

  日期：2011.12

  A facile method for the synthesis of tetralins has been described which uses various substituted phenylpentane-1,4-diones as starting material with a combination of TiCl4/Et3SiH. The synthesis involves three reactions under mild conditions. A mechanism has been proposed for the reductive cyclization through ionic hydrogenation, and titanium(IV) chloride catalyzed cyclization. (C) 2011 Elsevier Ltd. All rights reserved.